Ameliorative Potential of Dacryodes edulis Ethanol Leaf Extract in Testosterone-Induced Benign Prostatic Hyperplasia: In Vivo and in Silico Evidence
Abstract
BPH is a prevalent androgen-dependent disorder characterized by prostatic enlargement, inflammation, and oxidative stress. This study investigated the ameliorative potential of ethanol leaf extract of Dacryodes edulis against testosterone-induced BPH using in vivo and in silico approaches. Thirty-Seven male albino rats weighing 150 g were used and twenty-five (25) of them were rendered BPH by subcutaneous testosterone propionate administration and subsequently treated with ethanol leaf extract of Dacryodes edulis (300 and 600 mg/kg) or 5 mg/kg Finasteride. Acute toxicity assessment indicated a wide safety margin for the extract. In vivo findings showed that the 600 mg/kg ethanol leaf extract significantly mitigated BPH-associated alterations, including reductions in serum testosterone (13.75±0.60 ng/mL), prostate-specific antigen (0.14±0.02 ng/mL) and 5α-reductase activity (6.81±0.20 pg/mL) better than the Finasteride (i.e. the standard drug). Dacryodes edulis extract also improved antioxidant defense while reducing lipid peroxidation. Biochemical parameters were favorably modulated, suggesting systemic protective effects. Histopathological evaluation of the prostate, liver, kidney, and testes revealed marked restoration of normal tissue architecture. Preliminary molecular docking studies further demonstrated that bioactive compounds from ethanol leaf extract of Dacryodes edulis especially 2-Methyl-7-phenylindole (-9.0 kcal/mol), 2-ethylacridine (-9.0 kcal/mol) and…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.